Xolremdi

Active Ingredient(s): Mavorixafor
FDA Approved: * April 26, 2024
Pharm Company: * X4 PHARMS
* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Xolremdi 100 mg Oral Capsule, Gelatin Coated
NDC: 83296-100
Labeler:
X4 Pharmaceuticals, Inc.